Osteopontin (OPN) is a matricellular cytokine present in most tissues and body fluids; it is known to modulate immune responses. In previous studies using the dextran sulfate sodium (DSS) acute colitis model, we found exacerbated tissue destruction and reduced repair in OPN-null (À/À) mice compared with wild-type (WT) controls. As OPN is normally present in milk, we hypothesized that administration of OPN may protect the intestines from the adverse effects of experimental colitis. A volume of 20 or 2 mg/ml bovine milk OPN, dissolved in drinking water, was given to mice 24 h before, and during administration of DSS. Clinical parameters of colitis and neutrophil functions were analyzed as previously reported. Orally administered OPN was absorbed and detected in the colon mucosa by immunohistochemistry. The 20 mg/ml OPN-and DSS-treated WT mice showed 37% less weight loss and reduced colon shortening and spleen enlargements than control mice (Po0.05). OPN administration also reduced the disease activity index, improved red blood cell counts, and reduced gut neutrophil activity compared with the DSS-treated WT mice that were not administered OPN (Po0.05). Immunohistochemical detection of F4/80-labelled cells (macrophages) was also less frequent. The level of transforming growth factor b1 (TGF-b1) was increased and the levels of pro-inflammatory mediators decreased in colon tissue samples of OPN-treated mice analyzed by ELISA. The reversal of experimental colitis parameters by exogenous OPN was not as robust in the OPN À/À mice. Administration of prokaryotic-expressed recombinant OPN and bovine serum albumin were ineffective. This study shows that administration of a physiological concentration of milk OPN in drinking water ameliorates the destructive host response in DSS-induced acute colitis.
The pathogenesis of inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, is believed to involve increased host susceptibility combined with de-regulated immune responses to microbial and dietary antigens. [1] [2] [3] During colitis, neutrophils migrate into the lesion, and they are found within intestinal crypts and at the base of ulcerations, forming crypt abscesses. 4 Furthermore, several studies have shown that the total number of macrophages increases, including some subpopulations of macrophages that are not normally present in the lamina propria of the intestine. 5, 6 Macrophages together with neutrophils may contribute to intestinal damage by releasing radicals derived from oxygen metabolism 7 and by secreting pro-inflammatory cytokines and other inflammatory mediators. For our studies, we used the dextran sulfate sodium (DSS)-induced colitis model, which was first described by Okayasu et al, 8 and which has been extensively used in IBD studies. This murine model shows a deregulated inflammatory response coincident with many pathological changes that are similar to those seen in human ulcerative colitis. 8, 9 Although the lesions are rather uniform and reproducible, the time course and severity of the induced colitis mimics that seen in humans. 10 Consequently, DSS-induced murine colitis has been recognized as a valuable tool in the identification of potential therapeutic agents, and it is considered to be a sensitive screening system.
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Osteopontin (OPN) is a matricellular cytokine present in most tissues and body fluids. It has been suggested that OPN has an important modulatory role in innate immunity, which is reflected by its mucosal protective functions in some infectious diseases. 12 OPN is secreted by dendritic cells, activated macrophages, T lymphocytes, and subsequently by proliferating fibroblasts during reparative matrix formation. [13] [14] [15] We have shown that OPN is upregulated in epithelial cells of the intestinal mucosa during experimental colitis. 16 We have also shown that OPN is chemoattractive for neutrophils but not involved in phagocytosis or generation of reactive oxygen species. 17 Yet, OPN regulates macrophage functions such as migration, activation, and phagocytosis. [18] [19] [20] OPN-mediated initiation of healing appears to be associated with the upregulation of transforming growth factor b1 (TGFb1), which induces restitution of the intestinal epithelial barrier, decreases apoptosis of fibroblasts, and results in increased matrix deposition. [21] [22] [23] [24] Our previous study using the experimental acute colitis model found a greater susceptibility of OPN À/À mice than wild-type (WT) mice to DSS-induced colitis. 16 Clinical parameters of colitis, such as weight loss, disease activity scores, colon shortening, and spleen enlargement, were significantly greater in OPN À/À mice and accompanied by an exacerbation of intestinal tissue damage. Tissue destruction was associated with the persistence of neutrophils and reduced survival of enterocytes. Although OPN has been associated with a detrimental type 1 helper T-cell immune response in other inflammatory diseases, [25] [26] [27] [28] [29] it had important protective functions in our studies of acute colitis. OPN may modulate local immune responses by modifying innate immune cell functions and expression of inflammatory cytokines, thereby attenuating inflammatory tissue damage. This raised the question whether dietary exposure to exogenous OPN may be sufficient to restore an experimental colitis immune response that is less damaging. Therefore, we hypothesized that exogenous delivery of milk OPN in drinking water of mice may protect the colon from the adverse effects of DSS-induced inflammation. Our data show that bovine milk OPN at 20 mg/ml concentration, administered for 8 days in drinking water, ameliorated DSSinduced colitis in mice. It reduced the levels of innate immune cells and pro-inflammatory mediators in the diseased colon and diminished the classic hallmarks of the disease.
MATERIALS AND METHODS
Source and Biotinylation of OPN Samples of bovine milk OPN, containing a mixture of intact OPN and OPN-derived peptides, were prepared as described. 30 For preparation of recombinant OPN (r-OPN), a pET28a expression vector containing rat OPN cDNA was used to transform Escherichia coli BL21 cells. The recombinant protein was purified by nickel affinity chromatography and fast protein liquid chromatography as previously described for bone sialoprotein. 31 Biotinylated bovine milk OPN (b-OPN) was prepared as follows: 0.5 mg/ ml of OPN in a 50-mM sodium bicarbonate buffer (pH 8.5) was mixed with biotin-N-hydroxysuccinimide ester dissolved in dimethyl sulfoxide for 2 h at 41C, desalted on a 10-ml desalting column (PD-10 desalting columns, Amersham Biosciences, Piscataway, NJ, USA) equilibrated in 50 mM ammonium bicarbonate buffer (pH 8.5). A dot blot assay with streptavidin-horseradish peroxidase (HRP) was used to confirm the fractions containing OPN. The OPN was dried on a speed vacuum and reconstituted in phosphate-buffered saline (PBS), pH 7.2, at a concentration of 1 mg/ml.
DSS-Induced Experimental Acute Colitis in Mice and
Delivery of Exogenous OPN Approved animal experiments were conducted according to guidelines established by the Animal Care Committee of the University of Toronto. The generation and initial characterization of OPN À/À mice was described previously. 32 The original 129sv F2 mice were subsequently back-crossed (10 Â ) into a C57BL/6J background. Polymerase chain reaction (PCR) was used at regular intervals for genotyping of OPN À/À mice to confirm that the colony had not been contaminated. For these studies, we used adult OPN À/À males, 8-to 10-week old, and their matched C57BL/6J WT controls. The mice were housed in a specific pathogen-free facility with controlled temperature and light/dark cycles, and fed standard mouse chow pellets. DSS (DSS-36 000-50 000 MW; MP Biomedical, Aurora, OH, USA) 5% (wt/vol), dissolved in sterile distilled water, was given for 7 days to induce experimental colitis. 9 Control animals were given water only, and water consumption was monitored for both animal groups. Bovine milk OPN was dissolved in the drinking water at 20 mg/ml, representing the normal physiological concentration in bovine milk, or at 2 mg/ml. For short-term experiments to determine whether OPN would be detected in the colon tissues and in the blood after exogenous administration of OPN, a higher dose of 200 mg/ml, which approximates the physiological concentration of human milk, was also used. The OPN was continuously given to mice starting 24 h before administration of the DSS to induce colitis. The mice were killed after 7 days of DSS, which was the 8th day of OPN administration. In one set of experiments, bovine serum albumin (BSA) was used in place of OPN as an exogenous protein control. Similarly, the therapeutic impact of administering prokaryotic-expressed r-OPN, lacking typical post-translational modifications, was compared with that of the bovine milk OPN.
Analysis of Clinical Parameters
Clinical parameters were analyzed as previously reported. 16 Among other key variables (body weight, spleen enlargement, colon length, and water consumption), the parameters included variables originally described by Hartmann et al 33 as a 'disease activity index (DAI),' based on anal bleeding and the nature of the feces. Individual animal scores between 0 and 3 were used, with '0' referring to normal stool and no fecal blood and '3' for liquid stool and/or presence of blood on the cage wall. The mean±s.e.m. was determined for each group.
Detection of b-OPN and Murine OPN in Tissue Sections by Immunohistochemistry
The b-OPN and DSS were dissolved in the drinking water, and the mice were killed after 7 days of DSS treatment, as described above. The b-OPN was detected in sections of colon tissues by immunohistochemistry as previously described. 16 Briefly, frozen sections were fixed in 50% acetone, placed in ethanol for 10 min and stored at À201C for 2 days. The sections were incubated with 3% H 2 O 2 for 10 min to eliminate endogenous peroxidase activity and blocked with 1% BSA for 10 min. The sections were incubated with avidin and biotinylated HRP (Vectastain Universal Elite ABC kit) for 30 min, and then the HRP enzyme activity was visualized by adding the chromogenic substrate 3,3 0 -diaminobenzidine tetrachloride (DAB; Vector Laboratories, Burlingame, CA, USA) for 10 min, which results in brown staining. The expression of OPN in mouse colons was also examined by immunohistochemical analysis. The sections were incubated overnight with a rabbit anti-porcine OPN antibody, 34 affinitypurified using recombinant rat OPN, and the sections were incubated with goat anti-rabbit IgG for 30 min.
Plasma b-OPN Quantification b-OPN, 20 mg/ml in drinking water, was ingested ad libitum by 12 mice for 8 days. Eight additional mice were selected and treated with 1 ml of 20 or 200 mg/ml b-OPN by oral gavage. After 4 h, blood was collected from all the mice, and the resulting plasma stored at À801C. A modified sandwich ELISA was used to quantify the amount of b-OPN in the samples. Briefly, 100 ml of 4 mg/ml polyclonal rabbit antibody raised against bovine milk OPN was added to the wells of an enhanced protein-binding ELISA plate (Falcon, cat. no. 353279). As a negative control, some wells were left coatingfree. After incubation overnight at 41C, the plate was brought to room temperature, the capture antibody solution was removed, and the wells blocked by the addition of 200 ml of 0.05% Tween 20 and 1% BSA in PBS for 1 h. After washing three times with PBS/Tween, 100 ml of a plasma sample was added and incubated for 4 h at room temperature. The streptavidin-HRP conjugate was used at a dilution of 1:1000 in PBS. The substrate was added and absorbance at 490 nm determined (Titertek Multiskan reader; Titertek Instruments, Huntsville, AL, USA).
Peripheral Blood Cell Analyses
Approximately 0.5-1 ml of blood was collected by intracardiac puncture, placed in a labeled vial containing 1000 mg/ml heparin, and transported on ice for hematological analysis to VITA-TECH Laboratories (Toronto, ON, Canada). Blood samples were analyzed for total blood cells and differential white blood cell (WBC) counts, red blood cell (RBC) counts, hemoglobin, hematocrit, mean corpuscular hemoglobin, mean corpuscular volume, and mean corpuscular volume concentration.
Myeloperoxidase Activity
Myeloperoxidase (MPO) activity was analyzed in gut tissue samples as a surrogate variable to evaluate neutrophil accumulation and activity, using a commercial kit for the o-dianisidine assay (Cytostore, Calgary, AB, USA). Briefly, weighed gut strips that had been washed in PBS and stored at À801C were thawed, homogenized in a 0.5% hexadecyltrimethylammonium bromide in 50 mM phosphate buffer (pH 6.0), and clarified by centrifugation for 2 min at 9000 g at 41C. An aliquot of the supernatant was allowed to react with the chromogen (o-dianisidine dihydrochloride) in the presence of potassium phosphate buffer and 1% H 2 O 2 , as supplied by the manufacturer. The absorbance at 450 nm was measured immediately by spectrophotometry and again at 60 s after the addition of the chromogen to determine the reaction rate. Murine bone marrow neutrophils, isolated on a Percoll gradient, served as a positive control. MPO was expressed as the quantity of enzyme in 1 mg tissue that degraded 1 mmol/min of peroxide at 371C.
Macrophage Detection Using F4/80 Antibody Staining F4/80 antigen expression by macrophages was detected by immunohistochemistry using a rat monoclonal F4/80 antibody (ab6640, Abcam, Cambridge, MA, USA) to label sections of colon tissues. Briefly, frozen sections were fixed in 50% acetone, placed in ethanol for 10 min and stored at À201C. The sections were incubated with 3% H 2 O 2 for 10 min to eliminate endogenous peroxidase activity. After blocking with Rodent Block M (cat no. RBM961L, Biocare Medical LLC, Concord, CA, USA) for 30 min, the sections were incubated for 60 min at room temperature with 1:50 diluted rat anti-mouse F4/80 antibody. The sections were incubated with anti-rat IgG (Rat on Mouse HRP-Polymer Kit, cat no. RT517L, Biocare Medical LLC) for 30 min and then with the chromogenic substrate (DAB) for 10 min. Mouse spleen was used as the positive control; the primary antibody was omitted for the negative control.
Quantification of TGF-b1 and Cytokine Assay
The colon tissue samples were prepared as described above for the MPO assay, and aliquots were analyzed for TGF-b1 content. The TGF-b1 concentration was determined by a quantitative sandwich enzyme immunoassay technique using a commercial kit (Quantikine, R&D Systems, Inc., Minneapolis, MN, USA). In addition, the homogenized gut tissue samples were analyzed with an antibody-based protein array system to quantify secreted pro-inflammatory cytokines, such as granulocyte colony-stimulating factor (G-CSF), interferon gamma (IFN-g), macrophage colony-stimulating factor (M-CSF), tumor necrosis factor alpha (TNF-a), monokine induced by gamma-interferon (MIG), regulated on activation normal T cell expressed and secreted (RANTES), using TranSignalt Mouse Cytokine Antibody arrays (Panomics, Fremont, CA, USA). Changes in cytokine secretion were evaluated for each sample in relation to the mean density of the negative controls (0%) and the mean density of the positive controls (100%), supplied by the manufacturer, on each cytokine array membrane. The values are expressed as the percentage change (mean ± s.d.).
Statistical Analyses
Results are expressed as mean ± s.e.m. Experiments in vivo were carried out at least five times with three or more mice in each group, and analysis of tissues was carried out at least three times. The data were compared using one-way ANOVA analysis with the Bonferroni method as post hoc test. Statistical significance was defined as Po0.05. Calculations were carried out using the statistical analysis software SPSS (SPSS, Chicago, IL, USA).
RESULTS

Absorption of Bovine Milk OPN
To determine whether bovine milk OPN was absorbed during the course of OPN treatment, 20 mg/ml b-OPN was administered orally, and its concentration in plasma was determined using the ELISA method. b-OPN ingested ad libitum was not detected in the plasma of these mice. However, mice that also received either 20 or 200 mg/ml OPN by gavage had B145 and B1050 ng/ml of b-OPN in plasma, respectively ( Figure 1) . No reactivity was detected in the plasma of control mice administered OPN that was not biotinylated, either orally or by gavage.
Milk OPN Detection in Inflamed Colons
To investigate whether OPN was taken up by the diseased colon tissues, b-OPN was administered to DSS-treated mice. Immunostaining of controls, and sham and DSS-treated WT colon tissue that had been exposed to exogenous non-biotinylated OPN showed only a slight staining in the epithelial cells of the mucosa that may have been due to endogenous enterocyte biotin (Figure 2a Figure S3a-d) . All together, the results of these experiments showed that OPN was retained by the mucosa of the colon after exogenous administration of bovine milk OPN.
Milk OPN has Beneficial Effects on Clinical Outcomes in Experimental Colitis
Treatment of WT and OPN À/À mice with DSS produced clinical and histological signs of colitis, as we had reported previously; 16 yet the DAI scores for WT and OPN mice were not statistically different in the present data set (Supplementary Figure S5 ). DSS-treated WT mice lost weight from day 4 onward; in contrast, the DSS-treated mice that were administered 20 mg/ml milk OPN lost significantly less weight (Figure 3a ; Po0.05, n ¼ 9). The DSS-treated OPN À/À mice also lost weight; yet, administering them OPN diminished their weight loss only on day 6, (Po0.05, n ¼ 9). Water consumption measurements showed that DSS-treated mice that received the 20 mg/ml dose of OPN consumed more water (Figure 3b ; Po0.05, n ¼ 7). This finding suggests that they were less sick, although their increased water consumption would coincidently also increase their exposure to DSS. The DAI scores based on stool consistency and anal bleeding was B40% lower on the sixth and seventh day for the 20 mg/ml OPN group (Figure 3c ; Po0.001, n ¼ 9). Spleen enlargement, a marker of systemic inflammation, was calculated in proportion to the body weight. In the DSS-treated WT animals, 20 mg/ml OPN induced a smaller increase in the spleen weight (Figure 3d ; Po0.05, n ¼ 9). Similarly, colon length, a morphometric measurement of the degree of colitis, was not as short in the DSS-treated mice that had been given 20 mg/ml OPN as that in the other DSS-treated groups, for both WT and OPN À/À mice (data not shown). For some clinical parameters measured, the 2 mg/ml dose of OPN tended to induce partially protective effects, although not to the same degree as 20 mg/ml OPN (Figure 3a and c) . For most of the clinical indices analyzed, the administration of exogenous OPN led to the reversal of the measured parameters in DSS-fed WT mice, but to either no effect, or much less of an effect, in DSS-fed OPN À/À mice. Heparinized peripheral blood collected by intra-cardiac puncture on day 7 contained lower levels of RBC, hemoglobin, and hematocrit (data not shown) in mice treated 
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APB da Silva et al with DSS, which is indicative of hemorrhage. Blood from the mice administered 20 mg/ml OPN had greater levels of RBC and hemoglobin (Figure 4a and b; (25% increase; Po0.05, n ¼ 9), as well as hematocrit increased by B25% (data not shown), indicating decreased loss of fecal occult blood. However, the DSS-treated OPN À/À mice did not exhibit any significant difference in these parameters upon administration of OPN (Figure 4a and b) . These data suggest that beneficial effects of OPN in ameliorating the progression of colitis are not as readily achievable in OPN À/À mice. Differentiation analysis of WBC counts (Figure 4c-e) showed a statistically significant decrease in the level of neutrophils in DSS-treated mice that were administered 20 mg/ml OPN. The neutrophil count was markedly decreased by B43% (Figure 4e ; Po0.05, n ¼ 9). In contrast, in the OPN À/À mice, administration of 20 mg/ml OPN actually increased WBC counts (Figure 4c ). Differential analysis showed that both lymphocyte and neutrophil counts were elevated compared with DSS-treated controls (Figure 4d and e).
OPN Administration Reduces the Destructive Potential of Neutrophils and Leads to Lower Macrophage Counts during Experimental Colitis
MPO activity, a potentially tissue-destructive indicator of neutrophil infiltration, was increased markedly in samples of colon tissue from DSS-treated mice, with a greater increase in the colons of OPN À/À mice (Figure 5a ). It can be noted that treated WT mice administered 20 mg/ml OPN lost significantly less weight than the DSS-treated control mice on days 5, 6 and 7 (*Po0.05, n ¼ 9). The weight loss for the OPN À/À mice given 20 mg/ml OPN was significantly less than controls only on day 6 (*Po0.05, n ¼ 9). (b) Water consumption measurements showed that OPN-administered mice consumed more water (*Po0.05, n ¼ 7). (c) DSS-treated WT mice administered 20 mg/ml milk OPN exhibited DAI scores significantly lower on days 6 and 7 (**Po0.001, n ¼ 9). No statistically significant differences were found in the OPN À/À mice (n ¼ 9). (d) In the DSS-treated WT animals, 20 mg/ml of OPN led to a smaller increase in spleen size (*Po0.05, n ¼ 9), which was not seen in the OPN À/À mice (n ¼ 9).
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MPO was reduced in the colons of the WT mice that had been administered 20 mg/ml OPN (Figure 5a , Po0.05, n ¼ 7). Similarly, staining of colon sections with F4/80, a marker for macrophages, found that administration of 20 mg/ml milk OPN apparently led to decreased macrophage recruitment. In the sham-control WT colon, F4/80 þ staining was observed mostly in the submucosa (Figure 5b ). As noted in the control (Figure 5c ), no staining was observed in the absence of primary antibody. As expected, due to crypt destruction and high levels of pro-inflammatory cytokines, 16 F4/80 immunostaining in DSS-treated WT mice showed a large increase in the number of macrophages throughout the mucosa and submucosa (Figure 5d ). The administration of 20 mg/ml OPN to DSS-treated mice decreased macrophage (c-e) In the WT mice, OPN intake appeared to reduce the levels of WBC counts from the high levels of WBC seen in the control DSS-induced colitis blood samples. Differential analysis showed that neutrophils were markedly decreased in the OPN 20 mg/ml group (*Po0.05, n ¼ 9). In the OPN À/À mice, the 20 mg/ml dose of OPN led to higher WBC counts. Differential analysis showed that this increase occurred mainly due to lymphocytes (*Po0.05, n ¼ 9).
infiltration ( Figure 5e ). To better establish the architecture of tissue sections analyzed in Figure 5 , hematoxylin and eosin staining corresponding to these sections is shown in Supplementary Figure S4a -d.
Decreased Inflammation is Accompanied by Increased Levels of TGF-b during Experimental Colitis
TGF-b1 is both a pro-fibrotic growth factor and an immunosuppressive mediator that acts through various Role of OPN in DSS-induced acute colitis APB da Silva et al mechanisms, including downregulation of pro-inflammatory cytokines. Therefore, TGF-b1 expression in colon tissue lysates was compared among the OPN treatment and control groups. Colon tissue from DSS-treated WT mice, but not from OPN À/À mice, showed elevated levels of TGF-b1 ( Figure 6 ; Po0.001). Yet, when mice were administered 20 mg/ml milk OPN, the DSS-treated mouse colons from both WT and OPN À/À mice had even greater levels of TGFb1 than those of DSS-treated mice that did not receive exogenous OPN (Figure 6 ; WT, Po0.001; OPN À/À , Po0.05, n ¼ 5).
Decreased Inflammation upon OPN Administration is Coincident with Diminution of Pro-inflammatory Mediators
Extracts of gut tissues were analyzed for the presence of proinflammatory cytokines using cytokine antibody arrays. Values were calculated as a percentage of the positive controls (100%) in each array. DSS-treated WT colons exhibited significantly greater amounts (2-to 10-fold) of G-CSF, IFN-g, M-CSF, TNF-a, MIG, and RANTES than those of the sham group (Figure 7) . Administration of 20 mg/ml OPN to DSS-treated WT colons reduced the levels of these inflammatory mediators to that of the sham group, which received no DSS.
BSA and r-OPN Fail to Reproduce the Beneficial Effects of Milk OPN
In order to exclude the fact that the beneficial effects of OPN in experimental colitis were due to a general effect of administering exogenous protein in drinking water, a comparison of BSA and OPN administration was assessed in DSStreated mice. As before, 20 mg/ml OPN decreased the clinical signs of colitis (DAI scores, neutrophils) (Supplementary Figure S1a, b; Po0.05, n ¼ 5). In contrast, 20 mg/ml BSA had no effect in modulating the DSS-induced colitis (Supplementary Figure S1a, b) .
As it is known that various cellular responses to OPN are due to its post-translational modifications, 35 disease progression of experimental colitis was analyzed in DSS-treated mice administered either milk OPN or r-OPN, which contains no post-translational modifications. After 4 days of DSS treatment, the mice administered milk OPN showed lower scores for the DAI than those administered r-OPN (Figure 8a ; Po0.05, n ¼ 5). Peripheral blood analysis showed decreased levels of RBC and higher levels of WBC in the r-OPN group, indicating blood loss and acute inflammation (Figure 8b) . Moreover, r-OPN failed to reduce neutrophil and lymphocyte counts as observed for milk OPN (Figure 8c ). These results suggest that the post-translational modifications of milk OPN, such as phosphorylation, 35 are crucial for achieving the beneficial effects of exogenous OPN in DSS-induced colitis.
DISCUSSION Bovine Milk OPN Attenuates Acute DSS-Induced Colitis
In a previous study, we found a greater susceptibility of OPN À/À than WT mice to DSS-induced colitis. 16 This finding led us to ask whether the administration of exogenous OPN may have a protective effect during DSS-induced colitis. Our major findings in this study support this contention. We found that OPN (20 mg/ml) introduced for 8 days dissolved in the drinking water was detected in the colon mucosa (Figure 2 ). It ameliorated DSS-induced colitis in mice by diminishing signs of disease and by decreasing fecal occult blood loss, peripheral blood neutrophils, colon mucosa neutrophils, macrophages, and pro-inflammatory cytokines. Yet, others have shown that abrogation of the interaction between OPN and its receptors by antibodies specific for the SLAYGLR domain of OPN resulted in the amelioration of inflammatory diseases such as rheumatoid arthritis, hepatitis, and inflammatory ocular disease. [36] [37] [38] [39] Our findings suggest that the pathogenesis of acute colitis induced by DSS is different from that of these other inflammatory diseases, as it is a mucosal disease in which an intact mucosal epithelial barrier is required to combat intermittent bacterial influx. Therefore, in contrast to DSS-induced chronic colitis, in which OPN may induce polarization of the type 1 helper T-cell immune response to cause increased inflammation, 40 OPN may actually attenuate inflammation in DSS-induced acute colitis by contributing to the resolution of a deregulated innate immune response in the colon. Yet, there is a possibility that stimulation of adaptive immunity could account for some of the responses to bovine milk OPN administration.
Bovine Milk OPN Decreases Destructive Capacity of Neutrophils by Activating Macrophages
In the presence of OPN, macrophages infiltrating the injured mucosal tissues in early stages of acute inflammation help the neutrophils to combat invading pathogens, while concomitantly limiting the amount of damage by the neutrophils. 41 We have shown that the absence of OPN expression in OPN À/À mice leads to increased destructive activity of neutrophils and improper differentiation of macrophages. 16 However, we have also shown that the expression of OPN is not required for neutrophil destructive capacity. 17 This increased neutrophil activity may be due to slow clearance by OPN À/À macrophages, 42 which display impaired migration, 18 suggesting that they may also have reduced phagocytic activity in vivo. Our most recent data show that the oral administration of 20 mg/ml of bovine milk OPN led to a reduction in neutrophil activity (Figure 5a ) accompanied by an increase in the TGF-b1 expression ( Figure 6 ). These results suggest that exogenous OPN may act by restoring macrophage activity.
Effective elimination of neutrophils is a prerequisite for resolution of the inflammatory response. 43 One possibility in our colitis model is that exogenous OPN may contribute to the termination of inflammation by activating macrophages to take up apoptotic neutrophils, thereby leading to neutrophil clearance and the release of anti-inflammatory and reparative cytokines, such as TGF-b1. 44 Both in vitro and in vivo evidence suggest that secretion of TGF-b1 by macrophages can suppress pro-inflammatory signaling from Tolllike receptors, further stimulating tissue repair. 45, 46 The attenuation of an inflammatory reaction coincides with the departure of macrophages through the lymphatics. 43, 47, 48 The tissue mononuclear cell population (macrophages and lymphocytes) returns to normal preinflammation density and phenotypes. 49 In support of this concept, our immunohistochemistry analysis of colon sections indicates that oral administration of milk OPN decreased the macrophage population during DSS-induced colitis (Figure 5e ). Consequently, it is possible that once apoptosis of leukocytes and resident cells is engaged (an early event), subsequent uptake of apoptotic cells would cause a switch in macrophage phenotype from activated or injurious to reparative or migratory. Such a shift would also be expected to diminish the local production of pro-inflammatory cytokines, as we observed in our data set ( Figure 7 ). Exogenous milk OPN appeared to promote a more confined sequence of protective inflammatory responses, while limiting the intensity of the acute DSS-induced colitis.
TGF-b1, Restitution of the Mucosal Epithelial Barrier, and Healing
The intestinal mucosal barrier is formed by a monolayer of tightly joined epithelial cells that most often becomes disrupted during colitis. It has been shown that the intestinal mucosa promotes epithelial restitution after mucosal injury through the increased production of bioactive TGF-b1 by the epithelial cells 21 and by subepithelial myofibroblasts. 50 For example, epithelial monolayers pretreated with TGF-b1 completely abrogated the barrier-disrupting effect of the intestinal pathogen Cryptosporidium parvum oocysts. 51 In this study of experimental colitis, the beneficial effects of administering 20 mg/ml milk OPN was accompanied by a significant increase in TGF-b1 level in both OPN À/À and WT mice ( Figure 6 ). The increase in TGF-b1 level may have contributed to the maintenance of intestinal barrier integrity and intestinal healing in the mice that experienced less tissue destruction.
OPN Modification may be Crucial for its Attenuation of DSS-Induced Colitis
Post-translational phosphorylation of OPN has a significant impact on the biological functions of this protein. 35 Ashkar et al 13 reported that phosphorylation of the N-terminal domain of OPN is required for RGD-b 3 -integrin recognition, and subsequent induction of interleukin-12 expression in murine macrophages. Similarly, phosphorylation of OPN is required for its stimulation of RGD-mediated spreading and activation of macrophages. 52 Moreover, Al-Shami et al 53 have shown that OPN induces trophoblastic cell migration, which is a process that depends on the level of phosphorylation of OPN. It can be noted that the r-OPN that we used in our study of experimental colitis, derived from the rat OPN sequence, did not promote the protective effects that were clearly associated with administration of bovine milk OPN, which is highly phosphorylated. 54 Although no detrimental effects were associated with the use of the r-OPN, its lack of protective effects may be explained by its freedom from posttranslational modification. Alternatively, the different results for the two forms of OPN could have been due to their distinct phylogenetic source; divergence in primary sequence may have contributed to altered function. However, the functional domains of OPN are normally well conserved among species, 55 and it is more likely that such differences are due to the degree or position of phosphorylation.
Does the Efficacy of Exogenous Milk OPN Require Expression of Endogenous OPN?
In this study, we found that administration of milk OPN diminished the damaging effects of DSS more in the WT than in the OPN À/À mice. Although the OPN À/À mice, which express no endogenous OPN, experienced marginal protection, and therefore may have required a greater dose, we propose that intracellular OPN may be a critical cofactor for mediating the physiological responses required for the attenuation of DSS-induced colitis. Evidence to support this hypothesis comes from a number of studies that explored the relationship of CD44 and OPN. The intracellular form of OPN has a peri-membranous distribution, and it colocalizes with CD44 and ezrin-radixin-moesin proteins in migrating embryonic fibroblasts, activated macrophages, and metastatic breast cancer cells. [56] [57] [58] Impaired chemotaxis in OPN À/À macrophages 18 and osteoclasts 59 has been associated with reduced cell surface expression of CD44. Moreover, although expression of OPN is evidently required for the recruitment of CD44 to the cell surface in macrophages and osteoclasts, [58] [59] [60] this requirement is not evident in neutrophils. 61 The ligation of CD44 by OPN mediates chemotaxis and adhesion of fibroblasts 62 and the downregulation of interleukin-10 (IL)-10 expression in peritoneal macrophages. 13 Furthermore, it has been suggested that the extracellular OPN can provide temporary CD44 or more substantial integrin attachment complexes that are required for the motility and the chemotactic functions of migrating cells. 55 Consistent with this concept, Lee et al 63 showed that an OPN-CD44 interaction is able to increase integrin adhesion by activation of integrins through inside-out signaling, resulting in increased cell survival. Therefore, it is conceivable that macrophages of OPN À/À mice may not be fully activated in the presence of exogenous OPN, which could impair the phagocytosis of neutrophils by the macrophages. Indeed, the administration of exogenous OPN led to only a minor, insignificant decrease in MPO activity of tissues from the OPN À/À mice (Figure 5a ). In summary, this study shows that the administration of bovine milk OPN attenuates DSS acute colitis. The protective effect seems to depend on a post-translationally modified form of OPN, and it is diminished in mice that are genetically deficient in endogenous OPN expression. The mechanism by which exogenous OPN attenuates colitis may be due to (1) the modulation of the number of neutrophils and their destructive activities, (2) decreased pro-inflammatory cytokine release, and (3) restitution of the epithelial barrier through increased local expression of TGF-b1, all potentially affected through macrophage interactions.
